Norbrook Laboratories voluntarily recalls veterinary injectable drug productsMay 30, 2019Norbrook Laboratories is recalling 34 lots of veterinary injectable drug products over concerns related to sterility assurance. The U.K.-based company says products tested, released, and distributed within the U.S. were manufactured on an aseptic line, which did not pass process simulation tests. The recall was made as a precautionary measure, as according to Norbrook, no batches of product have been identified to contain microorganisms. The following products have been recalled: Carprieve Injection, CarproJect Injection, Levafen Injection, and OstiFen Injection (carprofen; 50 mg/mL). They are nonsteroidal anti-inflammatory drugs (NSAIDs) for the pain and inflammation relief associated with osteoarthritis and control of postoperative pain associated with soft tissue and orthopedic surgeries in dogs Loxicom Injection, EloxiJect Injection, and OstiLox Injection (meloxicam; 5 mg/mL) are NSAIDs used for the relief of pain and inflammation connected with orthopedic surgery, ovariohysterectomy, and castration in dogs and cats Enroflox Injection for Dogs 2.27% and EnroSite Injection for Dogs 2.27% (enrofloxacin; 22.7 mg/mL) are used for the management of diseases in dogs associated with bacteria susceptible to enrofloxacin Enroflox 100 Injection (enrofloxacin; 100 mg/mL) is an antimicrobial used for the treatment and control of bovine respiratory disease, for the treatment and control of swine respiratory disease, …
SPONSORED CONTENTOne dose protects for 12 months.One ProHeart® 12 (moxidectin) injection puts compliance in your control. + Get started
